Digital regulatory affairs

All-digital regulatory affairs: three opportunities ripe for exploitation

What is the potential for transforming the management of marketing authorisation through the intelligent application of digital data capture and processing? ProductLife Group’s Erick...

Is the UK leading the way in med tech and innovation?

Disrupting pharma - Necessity is the mother of innovation In a data-driven future of efficient, personalised healthcare, the only limitations will be the intelligence of...
Image of graduates: skills shortage in life sciences

Addressing the skills shortage in life sciences

How can collaboration help to fill the skills shortage gap to ensure that the UK can compete in the global future of life sciences? The...
enhancing patient care

Enhancing patient care through partnerships

Partnership, whether local or strategic, must add value in order to be successful, especially in the rare disease space. Partnership working between pharmaceutical companies and...
Smart phone image: Digital partnerships in pharma

Digital partnerships in pharma and the NHS

Can pharma and the NHS equal the fast pace of change necessary to fully embrace technological innovation? Over the last few years, slowly but surely,...
Man looking at petri dishes: academia and pharma

Partnerships between academia and pharma

As R&D across genetic and cellular therapies progresses, how important is the role of innovation in the world of academia to exploiting the full...
Heather Parkin: Roche and NHS

Roche and NHS Joint Working projects

How can we create a world-class system of care which fulfils the ambitions of the NHS Long Term Plan? Working together holds the key. We...
Pharma and NHS working in partnership for older patients

Pharma and NHS working in partnership

A partnership to improve outcomes for malnourished older patients has had a positive impact on this vulnerable and often marginalised group. The challenges Tackling the crisis There...
Illustration of people meeting at a table that looks like a pill: meeting customer needs

The three stage plan for meeting customer needs

Taking a fresh look at NHS engagement is where success in meeting customers’ needs lies. But how? David Southern explores.  Existing commercial models of UK...
The future of genomics

The future of genomics and precision medicine

How is the use of genomics data enhancing our medical understanding and what does this mean for the future of precision medicine? Genomics is one of...

Latest articles

Oral health has been isolated from traditional healthcare and health policy for too long fuelling an oral health crisis according to a Lancet Series.

Big Sugar and neglect by global health community fuel oral health crisis 

Oral health has been isolated from traditional healthcare and health policy for too long, despite the major global public health burden of oral diseases,...
New statistics show decrease in animals used for R&D

New statistics show decrease in animals used for R&D

The Home Office has released its annual statistics on animals used in research in Great Britain. It shows 3.52 million procedures were carried out...
New insight into microRNA function has been published by scientists at the University of Eastern Finland and the University of Oxford.

New insight into microRNA function can give gene therapy a boost

New insight into microRNA function has been published by scientists at the University of Eastern Finland and the University of Oxford. They have shown that...

Popular articles

pain relief patch released by nurofen

Nurofen launches a 24 hour ibuprofen pain relief patch

Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen.  Despite body pain being among the most commonly...
NICE has approved a first-in-class gene silencing therapy for hereditary amyloidosis.

Gene silencing therapy for hereditary amyloidosis approved by NICE

NICE has approved a first-in-class gene silencing therapy for hereditary amyloidosis. RNA interference (RNAi) therapeutics company, Alnylam UK Limited has welcomed a decision from the...
AstraZeneca to appeal NICE's osimertinib decision

AstraZeneca to appeal NICE’s osimertinib decision

AstraZeneca to appeal NICE's osimertinib decision following it not being recommended for use within NHS England. AstraZeneca will appeal a decision by the National Institute...

Top 5 R&D hubs in the UK

Read this cover story in the June issue of Pf Magazine here.    Join us on a tour of inspirational research and development centres. ...

How to write a standout CV

The job market is getting more competitive by the day, as highly-qualified candidates fiercely compete for the top jobs. A carefully constructed CV is...